JILLIAN OWENS: Open Payments
NPI 1174913859 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,225 in 113 payments from 17 companies in 2025. Trend: 2023 $991 · 2024 $1,288 · 2025 $2,225
Food & beverage: $2,214Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $589 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $321 |
| Janssen Biotech, Inc. | 15 | $290 |
| Regeneron Healthcare Solutions, Inc. | 5 | $167 |
| Lilly USA, LLC | 7 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $144 |
| Ardelyx, Inc. | 5 | $114 |
| Aimmune Therapeutics, Inc. | 5 | $99 |
| Gilead Sciences, Inc. | 5 | $97 |
| Celltrion USA Inc. | 3 | $68 |
Products named: XIFAXAN, TREMFYA, RINVOQ, DUPIXENT, CREON, OMVOH, IBSRELA, ZENPEP.
Industry payments across MS — which companies pay providers there.
